# Open Orphan moving its registered office

- Link: https://www.directorstalkinterviews.com/open-orphan-moving-its-registered-office/412807311
- Published: 2020-03-02T15:35:44+00:00
- Author: Amilia Stone

**Open Orphan PLC** ([LON:ORPH](https://www.directorstalkinterviews.com/company/open-orphan-plc/orph.l)),
the rapidly growing specialist CRO pharmaceutical services company which has a focus
on orphan drugs and is a world leader in the provision of virology and vaccine challenge
study services, announces that the Company is moving its registered office and that,
with effect from today, the registered office address will change to Queen Mary 
BioEnterprises Innovation Centre, 42 New Road, London, E1 2AX.

**Notes to Editors:**

Open Orphan is a rapidly growing specialist CRO pharmaceutical services company 
which has a focus on orphan drugs and is a world leader in the provision of virology
and vaccine challenge study services and viral laboratory services. It has Europe’s
only 24-bedroom quarantine clinic with onsite virology lab in Queen Mary’s Hospital
London. hVIVO supports product development for customers developing antivirals, 
vaccines and respiratory therapeutics, all particularly relevant and topical in 
the environment of heightened awareness of the Coronavirus in 2020. The company 
also has a leading portfolio of 8 viral challenge study models which are: 2 FLU,
2 RSV, 1 HRV, 1 Asthma, 1 cough and 1 COPD viral challenge models.  No other company
in the world has such a portfolio, with only two competitors globally having 1 challenge
study model each. 

Share on:
